| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d777297c4464f0c1a0f824ce0318798
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_517e9b837d58a08398059b1ae1c2a833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7920fd0b8d62068d5e4f716c790c2c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2890bc52d94ddf6264dfdfefac99c610
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eae1ed318f306f964213f8626fa49c86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a31b3b59991ba07fbd69849b2dee0572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_233eae00e6af16809de05b947c83d963
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_774aaefb5bb7b905acfa3a3f364771e6 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10 |
| filingDate |
2001-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0585e67c5adf8760600f0ad61a2a49b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ead08e296f4666546e1c743d4b2e31c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2a6cacfc99a329e3033ae956f4a6822
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ca75f91bea2062826419a95a20fc0b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f97630dd1d903e29be731beadbd1818b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3c4a013576e852c44b582bbba806daf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2254691c4cd3816fac7acc0323f82ce0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81936151541c5810cdca968680fdea53 |
| publicationDate |
2002-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2193401-C1 |
| titleOfInvention |
Method for treating hyperactivity of urinary bladder |
| abstract |
FIELD: medicine. SUBSTANCE: the method deals with treating the disfunction of urinary bladder specified by detrusor's hyperactivity. The method is represented by instillation of anticholinergic preparation containing oxybutinine hydrochloride at physiologically acceptable dosage. The novelty is that this one additionally contains dimexide and aqueous solution of polyvinyl alcohol. Moreover, the mentioned preparation should be injected as a solution at standard volume of 20 ml at single dose in a day to remove all clinical signs of the disease. The method enables to improve transepithelial penetration of oxybutinine through urinary bladder's mucosa. EFFECT: higher efficiency of therapy. 1 cl, 1 tbl |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2714444-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2603471-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2597156-C2 |
| priorityDate |
2001-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |